Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix, BioDiscovery to Co-market Data Analysis Tools for OncoScan Service


Affymetrix will market BioDiscovery's Nexus Copy Number data analysis tool to users of its OncoScan FFPE Express Service, the companies said this week.

Under the terms of the deal, customers accessing the OncoScan FFPE Express Service through Affymetrix Research Services Laboratory will receive a preliminary Nexus Copy Number data analysis.

Additionally, BioDiscovery will provide a "one-on-one consultation session" to assist researchers with the downstream analysis of their data to "elucidate pathways and identify copy number variations and copy-neutral loss of heterozygosity events."

BioDiscovery has customized its Nexus Copy Number software to provide analysis of OncoScan FFPE Express microarray data, the companies said, but did not elaborate.

Affy launched the second version of the service last month. OncoScan FFPE Express 2.0 enables users to analyze DNA from formalin-fixed, paraffin-embedded tissues to extract retrospective clinical data from archived samples (BAN 4/5/2011).